Cell Viability Assays Global Market 2024 - Size, Share, Trends, Outlook To 2033

The Business Research Company recently released a comprehensive report on the Global Cell Viability Assays Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.

Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=16014&type=smp

According to The Business Research Company's, The cell viability assays market size has grown rapidly in recent years. It will grow from $1.41 billion in 2023 to $1.56 billion in 2024 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to increased investment in cancer research, growth in pharmaceutical R&D expenditure, growth in the biotechnology sector, increased advancements in cell culture techniques, rise in demand for stem cell research, rise in the need for toxicity testing, rise in the utilization of real time cell analysis systems, rise in the number of CROs (contract research organizations).

The cell viability assays market size is expected to see rapid growth in the next few years. It will grow to $2.34 billion in 2028 at a compound annual growth rate (CAGR) of 10.6%.The growth in the forecast period can be attributed to increasing demand for personalized medicine, rise in government funding for cell based research, increasing focus on precision medicine, growth in stem cell research and applications, increasing availability of automated cell viability analyzers, rise in the incidence of infectious diseases, increasing focus on improving assay accuracy and sensitivity, increasing awareness about the benefits of cell viability assays, rise in the development of organ on a chip technologies, increasing demand for regenerative medicine. Major trends in the forecast period include advancement in high throughput screening methods, implementation of AI and machine learning algorithms, development of real time monitoring systems, adoption of automated liquid handling systems, development of multiplex assays to simultaneously measure cell viability, adoption of more sustainable and eco friendly reagents, development of user friendly assay kits, advancement in electrochemical assays, implementation of scalable cell viability assays, development of assays compatible with primary cells and stem cells.

Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/cell-viability-assays-global-market-report

Market Drivers and Trends:

The increasing cell-based therapeutics is expected to propel the growth of the cell viability assay market going forward. Cell-based therapeutics refer to treatments that use living cells to repair or replace damaged tissue, treat diseases, or restore normal function. Cell-based therapeutics are fueled by advances in biotechnology, increasing investment in regenerative medicine, growing acceptance and adoption of cell therapies, and improvements in cell engineering and manufacturing technologies. Cell viability assays support cell-based therapeutics by ensuring the health, functionality, and safety of therapeutic cells, thereby optimizing treatment efficacy and quality control. For instance, according to the American Society of Gene & Cell Therapy, a US-based non-profit medical and scientific organization, 38 trials were initiated for non-genetically modified cell therapies in Q1 2023, 7 more than the previous quarter, Q4 2022. Therefore, increasing cell-based therapeutics is driving the growth of the cell viability assay market.

Major companies operating in the cell viability assays market are developing innovative cell screening technologies to improve accuracy and speed up drug discovery. Cell screening technologies enhance cell viability assays by enabling high-throughput, precise, and rapid analysis of cell health and responses, thus optimizing experimental conditions and improving the development of therapeutic strategies. For instance, in May 2024, Arralyze, a Germany-based technology company, introduced CellShepherd, a cutting-edge platform for single-cell analysis. It utilizes proprietary nanowell glass arrays to miniaturize cell-based assays for real-time monitoring. The autonomous system offers precise cell dispensing, co-culturing in sterile conditions, and imaging with brightfield and fluorescent channels. The AI-driven analysis guarantees accurate cell counting and tracking. This user-friendly platform addresses the increasing need for precise single-cell research in biomedical and life science applications.

Key Benefits for Stakeholders:

• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.

Major Key Players of the Market:

Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson, and Company, Agilent Technologies Inc., Lonza Group Ltd., PerkinElmer Inc., Sartorius AG, Charles River Laboratories, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Beckman Coulter Inc., Promega Corporation, Abcam Limited, MP Biomedicals, Cayman Chemical Company, Cell Signaling Technology Inc., Enzo Biochem Inc., Creative Bioarray, Abnova Corporation, Biotium, Canvax, Nexcelom Bioscience LLC, G-Biosciences, AAT Bioquest Inc.

Cell Viability Assays Market 2024 Key Insights:

• The cell viability assays market size is expected to see rapid growth in the next few years. It will grow to $2.34 billion in 2028 at a compound annual growth rate (CAGR) of 10.6%.
• Role Of Cell-Based Therapeutics In Driving The Growth Of The Cell Viability Assays Market
• Innovative Cell Screening Technologies Revolutionize Drug Discovery
• North America was the largest region in the cell viability assays market in 2023

We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=16014&type=smp

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.